Search

Your search keyword '"Multiple myeloma -- Reports"' showing total 135 results

Search Constraints

Start Over You searched for: Descriptor "Multiple myeloma -- Reports" Remove constraint Descriptor: "Multiple myeloma -- Reports" Topic physical fitness -- reports Remove constraint Topic: physical fitness -- reports
135 results on '"Multiple myeloma -- Reports"'

Search Results

1. New Multiple Myeloma Study Findings Have Been Reported by Researchers at National Cancer Institute (NCI) (Irf4 Requires Arid1a To Establish Plasma Cell Identity In Multiple Myeloma)

2. Data on Multiple Myeloma Reported by Researchers at University of Miami (The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans)

Catalog

Books, media, physical & digital resources

3. Harvard Medical School Researchers Have Provided New Study Findings on Multiple Myeloma (Mezigdomide-A Novel Cereblon E3 Ligase Modulator under Investigation in Relapsed/Refractory Multiple Myeloma)

4. Researcher from University of Saskatchewan Reports Recent Findings in Multiple Myeloma (A Novel Single-Tube Next Generation Sequencing Assay for B-Cell Receptor Clonality Testing)

6. University of Texas MD Anderson Cancer Center Researchers Provide Details of New Studies and Findings in the Area of Blood Cancer (Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or ...)

7. University of Torino Researchers Provide New Study Findings on Multiple Myeloma (Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?)

8. University of Milan Researchers Report Recent Findings in Multiple Myeloma [Single-Cell RNA Sequencing for the Detection of Clonotypic V(D)J Rearrangements in Multiple Myeloma]

9. Researchers from Harvard Medical School Provide Details of New Studies and Findings in the Area of Multiple Myeloma (Molecular Crosstalk between Chromatin Remodeling and Tumor Microenvironment in Multiple Myeloma)

10. Data on Multiple Myeloma Discussed by Researchers at Duke University Medical Center (Mechanistic Studies and a Retrospective Cohort Study: The Interaction between PPAR Agonists and Immunomodulatory Agents in Multiple Myeloma)

11. Studies from H. Lee Moffitt Cancer Center and Research Institute Reveal New Findings on Blood Cancer (Characteristics of Inpatients With Blood Cancers Who Experience a Fall: a Retrospective Study)

12. Researchers' from University of Genoa Report Details of New Studies and Findings in the Area of Multiple Myeloma [Myeloma Spine and Bone Damage Score (MSBDS) on Whole-Body Computed Tomography (WBCT): Multiple Reader Agreement in a Multicenter ...]

13. Researchers at Institute of Hematology and Transfusion Medicine Have Published New Data on Multiple Myeloma (Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing)

14. Studies from Fred Hutchinson Cancer Research Center Add New Findings in the Area of Multiple Myeloma (High-throughput Drug Screening and Multi-omic Analysis To Guide Individualized Treatment for Multiple Myeloma)

15. Reports from University of Messina Describe Recent Advances in Multiple Myeloma (Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells)

16. Studies from Zhejiang University Add New Findings in the Area of Multiple Myeloma (Rna Demethylase Alkbh5 Promotes Tumorigenesis In Multiple Myeloma Via Traf1-mediated Activation of Nf-kappa B and Mapk Signaling Pathways)

17. New Nucleoproteins Study Findings Have Been Reported by Researchers at IRCCS Regina Elena National Cancer Institute (CK2-mediated phosphorylation of Che-1/AATF is required for its pro-proliferative activity)

18. Recent Findings from Cleveland Clinic Provides New Insights into Venous Thromboembolism (Validation of the Impede Vte Score for Prediction of Venous Thromboembolism In Multiple Myeloma: a Retrospective Cohort Study)

19. New Findings Reported from Tyrolean Cancer Research Institute Describe Advances in Multiple Myeloma (Multiple Myeloma Inhibitory Activity of Plant Natural Products)

20. Investigators at Santiago University Clinical Hospital Detail Findings in Multiple Myeloma (Evaluation of Virola Oleifera Activity In Musculoskeletal Pathologies: Inhibition of Human Multiple Myeloma Cells Proliferation and Combination Therapy ...)

21. Findings on Multiple Myeloma Reported by Investigators at National University of Ireland Galway (A Worm Gel-based 3d Model To Elucidate the Paracrine Interaction Between Multiple Myeloma and Mesenchymal Stem Cells)

22. Jagiellonian University Medical College Researchers Detail New Studies and Findings in the Area of Multiple Myeloma (Evaluating the Relationship of GDF-15 with Clinical Characteristics, Cardinal Features, and Survival in Multiple Myeloma)

23. New Multiple Myeloma Study Findings Have Been Reported by Researchers at Santa Casa Medical School (Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care In Latin America for Transplant-ineligible Newly Diagnosed ...)

24. New Multiple Myeloma Study Results Reported from National Cancer Institute (NCI) (A Small Molecule Stabilizer of the MYC G4-Quadruplex Induces Endoplasmic Reticulum Stress, Senescence and Pyroptosis in Multiple Myeloma)

25. Investigators at University of Barcelona Have Reported New Data on Multiple Myeloma (The BCL-2 family members NOXA and BIM mediate fluorizoline-induced apoptosis in multiple myeloma cells)

26. Investigators at Mater Misericordiae University Hospital Have Reported New Data on Multiple Myeloma (Saliva-omics in plasma cell disorders- Proof of concept and potential as a non-invasive tool for monitoring disease burden)

27. Researchers at Wuhan University Report New Data on Multiple Myeloma (Strong Correlation Between the Expression of Chek1 and Clinicopathological Features of Patients With Multiple Myeloma)

28. Researchers at Tianjin Medical University Report New Data on Multiple Myeloma (Involvement of Mm Cell-derived Exosomes In T Lymphocytes Immune Responses)

30. Researchers from Odense University Hospital Report Findings in Bone Diseases and Conditions (Multiple Myeloma Associated Bone Disease)

31. Researchers' from Shandong University School of Basic Medical Sciences Report Details of New Studies and Findings in the Area of Pain (The Actions and Mechanisms of P2X7R and p38 MAPK Activation in Mediating Bortezomib-Induced Neuropathic Pain)

32. Data on Blood Cancer Published by Researchers at Rajshahi University of Engineering & Technology (Twin core photonic crystal fiber refractive index sensor for early detection of blood cancer)

34. Reports from Chinese Academy of Sciences Add New Data to Findings in Multiple Myeloma (A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe)

35. Aristotle University of Thessaloniki Researchers Report Recent Findings in Apoptosis (TRAF3 can interact with GMEB1 and modulate its anti-apoptotic function)

36. Studies from University of Milan in the Area of Myeloma Published (Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma)

37. Investigators from Oslo University Hospital Target Multiple Myeloma (NETs analyzed by novel calprotectin-based assays in blood donors, and patients with multiple myeloma or rheumatoid arthritis. A pilot study)

38. New Multiple Myeloma Study Findings Have Been Reported by C. Botta and Co-Researchers (Immunogenomic identification and characterization of granulocytic myeloid derived suppressor cells in multiple myeloma)

39. Reports Outline Multiple Myeloma Study Results from Chinese Academy of Medical Science & Peking Union Medical College (Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s)

40. Findings from Chinese Academy of Sciences Has Provided New Information about Multiple Myeloma (A novel phosphoramide compound, DCZ0847, displays in vitro and in vivo anti-myeloma activity, alone or in combination with bortezomib)

41. New Personalized Medicine Findings from Fondazione IRCCS Istituto Nazionale dei Tumori Published (Next-Generation Sequencing for Clinical Management of Multiple Myeloma: Ready for Prime Time?)

42. Report Summarizes Molecular Cancer and Carcinogenesis Study Findings from UCL School of Pharmacy (Is the Fate of Clinical Candidate Arry-520 Already Sealed? Predicting Resistance in Eg5-Inhibitor Complexes)

43. New Multiple Myeloma Findings Reported from Institute of Hematology and Transfusion Medicine (Decreased Activity of Blood Acid Sphingomyelinase in the Course of Multiple Myeloma)

44. Research from Karolinska Institute Reveals New Findings on Multiple Myeloma (Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry)

45. Reports Outline Molecular Cancer and Carcinogenesis Study Results from UCL School of Pharmacy (Is the Fate of Clinical Candidate Arry-520 Already Sealed? Predicting Resistance in Eg5-Inhibitor Complexes)

46. Data on Multiple Myeloma Discussed by Researchers at IRCCS San Raffaele Scientific Institute (ATR addiction in multiple myeloma: synthetic lethal approaches exploiting established therapies)

47. Investigators at Second Affiliated Hospital of Nanchang University Report New Data on Xenografts (Long non-coding RNA H19 promotes tumorigenesis of multiple myeloma by activating BRD4 signaling by targeting miR-152-3p)

48. Recent Findings from National University Cancer Institute Has Provided New Information about Multiple Myeloma [Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial ...]

49. National University Cancer Institute Describes Findings in Multiple Myeloma [Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network]

50. Data on Squamous Cell Carcinoma Described by Researchers at Southeast University (Decreasing New York esophageal squamous cell carcinoma 1 expression inhibits multiple myeloma growth and osteolytic lesions)